Clinical Trial Update: Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating a regimen that combines FDA-approved HIV drugs for patients with early virologic failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Investigational regimen combining FDA-approved HIV drugs

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infection | Phase 4 | Status: COMPLETED